DIAMOND Research Programme

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

• Frank Moriarty@frankmoriarty.bsky.social12/02/2026 10:23

  Our first paper from the @diamond-derx.bsky.social research programme funded by @wellcometrust.bsky.social is out! We sought to understand how simulation studies in pharmacoepidemiology have been conducted, led by Dr Ryan Muddiman @rcsi.bsky.social

  Ver post
• Frank Moriarty@frankmoriarty.bsky.social27/06/2025 12:10

  Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...

  Ver post
• Barb Farrell@barbfarrell.bsky.social23/06/2025 19:15

  #deprescribing needs careful monitoring. This week, restarted medication (albeit at lower doses than originally taking) for 2 patients whose symptoms worsened after stopping. A deprescribing success - found out the medication likely helping more than harming; now will assess response to confirm.

  Ver post
• CADeN | ReCAD@caden-recad.bsky.social23/06/2025 19:15

  New study reports facilitators and barriers to pharmacist-led antihypertensive deprescribing in LTC. Top barriers include structural barriers, time and lack of support, raising a need for greater interprof. collab. and public awareness of deRXing. onlinelibrary.wiley.com/doi/10.1111/...

  Ver post
• JAMA Internal Medicine@jamainternalmed.com23/06/2025 19:15

  Combining physician academic detailing with patient previsit activation increased diabetes medication deprescribing among older patients with type 2 diabetes. https://ja.ma/4ecZ31S

  Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.